Organigram first began as a medical cannabis provider. Today, the Company is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. The Company has one of the lowest cultivation costs per gram1 among Canadian LPs primarily attributable to high yields and operational efficiencies driven by a relentless culture of continuous improvement and the use of a unique and proprietary software system, OrganiGrow. Organigram has also reported positive adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) for its fiscal 2019 year and its first quarter fiscal 2020
OrganiGram Holdings Inc.
HQ: Toronto, Ontario
Organigram Holdings Inc is a licensed producer of medical marijuana. The Company, through its subsidiary, produces condition specific medical marijuana for patients.